U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

ERX9472328: Illumina HiSeq 2500 sequencing; Ribosome profiling of the genome-reduced bacterium Mycoplasma pneumoniae
1 ILLUMINA (Illumina HiSeq 2500) run: 213.1M spots, 10.7G bases, 4.4Gb downloads

Design: Ribosome profiling of the genome-reduced bacterium Mycoplasma pneumoniae
Submitted by: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Bioinformatics and Genomics. (Centre for Genomic Regulation (CRG), The Barcelona)
Study: Ribosome profiling of the genome-reduced bacterium Mycoplasma pneumoniae
show Abstracthide Abstract
In order to study quantitatively the translation efficiency in the genome-reduced bacterium Mycoplasma pneumoniae, we performed ribosome profiling (ribo-seq) in standard growth conditions. We first tested whether the ribosome profiling method could be applied to M. pneumoniae and assessed the quality of the obtained data. Mpn present some characteristics that differ from other model bacterial species where ribosome profiling has been established, like the absence of a cell wall, different lipid composition and low number of ribosomes (200-300 per cell compared with ~55,000 in E. coli). Thus, several aspects of the original method (Ingolia et al., 2009) had to be adapted. As a reference, we also performed ribosome profiling in E. coli. We also calibrated the ribosome P-site shift from the 3' end of ribosome protected footprints (RPFs) by analyzing the metagene profile of a sample treated with tetracycline.
Sample: MPN_RP4_P2_FP_13860_ACTGAT
SAMEA110321595 • ERS12419203 • All experiments • All runs
Library:
Name: MPN_RP4_P2_FP_13860_ACTGAT_s
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: other
Layout: SINGLE
Construction protocol: M. pneumoniae cell cultures were grown in Haylick rich medium as previously described (Yus et al., 2009) for 72h, split into biological duplicates and grown for 6h (exponential phase, standard conditions). In order to block ribosomes at the initiation stage, cells were treated with 40μg/ml of tetracycline during 1 min before lysis. Except for tetracycline-treated samples, cells were treated during 1 min with chloramphenicol at 100 μg/ml final concentration in order to stop translation. After treatment cell media was removed and cells were harvested by scraping and centrifuged at 8000g during 5 min in a 2 ml tube. Supernatant was discarded and cell pellet was resuspended in 1.5ml of lysis buffer, once pellet was resuspended lysis pressure was applied using a prechilled 4639 Cell Disruption Vessel (two passes). The cell lysate was centrifuged in a cooled desktop centrifuge at 16000g for 13 min and the supernatant was frozen into liquid nitrogen for further procedures. In order to block ribosomes at the initiation stage, cells were treated with 40μg/ml of tetracycline during 1 min before lysis. Except for tetracycline-treated samples, cells were treated during 1 min with chloramphenicol at 100 μg/ml final concentration in order to stop translation. In order to get ribosome footprints, a controlled digestion with MNase was performed as described in (Becker et al., 2013). Digestion reaction was stopped with EGTA. With the purpose of isolating ribosomes, a sucrose cushion was performed. We loaded the supernatant lysate onto 45 ml of 25% (for E. coli cells) or 15% (for Mpn cells) sucrose cushion buffer and ultracentrifuged the samples at 45000 rpm during 4h and 30 min at 4 C in a TI-45 rotor Beckman. The cushion buffer was removed carefully with a vacuum system and the pellet resuspended with 200μl of wash buffer. Finally 900μl of Trizol was added in order to perform RNA extraction (manufacture instructions). Once the RNA was purified, we isolated the footprints following the steps described in (Becker et al., 2013) in supplementary methods, page 6, sections “Size selection of the footprint fragments” and “Dephosphorylation”. Libraries were prepared using the NEBNext® Small RNA Library Prep Set for Illumina® kit (ref. E7330) according to the manufacturer's protocol. Briefly, 50ng of RNA were subjected to adaptor ligation at 3´and 5´ and first strand cDNA synthesis. After that, PCR selectively enriched those DNA fragments that had adapter molecules on both ends. Library amplification was performed by PCR using NEBNext® Multiplex Oligos for Illumina (Index Primers Set 1, ref. E7335). All purification steps were performed using AgenCourt AMPure XP beads (ref. A63882, Beckman Coulter). Final libraries were analyzed using Agilent Bioanalyzer (ref. 5067-4626) to estimate the quantity and check size distribution. Libraries were quantified by qPCR using the KAPA Library Quantification Kit (ref. KK4835, KapaBiosystems) prior to amplification with Illumina's cBot.
Experiment attributes:
Experimental Factor: organism: Mycoplasma pneumoniae M129
Experimental Factor: compound: chloramphenicol
Experimental Factor: fraction: ribosome footprints
Runs: 1 run, 213.1M spots, 10.7G bases, 4.4Gb
Run# of Spots# of BasesSizePublished
ERR9928769213,065,90010.7G4.4Gb2023-09-16

ID:
29532905

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...